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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S238performed in this study we obtained DNA from 402 patients with
osteoarthritis and 5348 controls. 186 of the patients were categorized to
a group of ‘probable osteoarthritis’ and 216 to a group of ‘deﬁnite
osteoarthritis’ using standard criteria based on medical history, symp-
tom history and physical status. The genotypes were determined by
PCR-based methods, iPlex/Sequenom MALTI-TOF mass array analyzer
and OpenArray. Background data were collected by a questionnaire.
Associations between the SNPs and knee OA were studied by SAS and
IBM SPSS statistical package Version 20.
Results: The nucleotide substitution A>T in FTO gene (rs9939609)
was found to correlate with osteoarthritis. Surprisingly this correla-
tion was statistically signiﬁcant only in the ‘probable osteoarthritis’-
group (OR ¼ 1,566, 95% CI: 1,040-2,360; p ¼ 0,032) and not in the
‘deﬁnite osteoarthritis’ group (OR ¼ 1,063, 95% CI: 0,713-1,584; p ¼
0,765). The result remained signiﬁcant in the ‘probable osteoarthritis’
group when adjusted with age and gender (OR ¼ 1,608, 95% CI:
1,047-2,470; p ¼ 0,030). When adjusted with BMI, the signiﬁcance
became non-signiﬁcant (OR ¼ 1,526, 95% CI: 0,990-2,344; p ¼
0,056).
Conclusions: Our results suggest that FTO gene has a role in knee OA.
However, it seems that the interaction is at least partly explained by
BMI.Change in semi-quantitative feature at 24 months and prediction of case control status OR (95% CI) p
Semi-quantitative feature Case (JSL and pain) (n ¼ 194)
vs. all controls (n ¼ 406)
Super Control
(n ¼ 200)
Pain Case (n ¼ 103) JSL Case (n ¼ 103) Case (JSL and pain) (n ¼ 194)
Change in number of subregions
affected by any BML
1.1 (1.0,1.4) 0.1572 Ref 1.0 (0.8,1.3) 0.8961 1.4 (1.1,1.8) 0.0059 1.3 (1.0,1.6) 0.0375
Max change in BML score across
all subregions in knee
1.2 (1.0,1.4) 0.0122 Ref 0.9 (0.7,1.1) 0.3548 1.5 (1.2,1.9) 0.0013 1.3 (1.1,1.6) 0.0037
Change in number of medial
tibio-femoral subregions
affected by any BML
1.5 (1.1,1.8) 0.0023 Ref 0.9 (0.6,1.4) 0.7385 2.0 (1.4,2.8) 0.0002 1.8 (1.3,2.5) 0.0001
Max change in BML score in
medial tibio-femoral subregion
1.5 (1.3,1.8) <0.0001 Ref 1.0 (0.8,1.4) 0.7878 2.3 (1.8,2.9) <0.0001 2.0 (1.6,2.5) <0.0001
Change inter-condylar synovitis 2.2 (1.4,3.6) 0.0015 Ref 1.0 (0.5,2.2) 0.9106 1.7 (0.8,3.6) 0.1615 2.6 (1.4,4.7) 0.0018
Change in whole knee effusion 2.2 (1.6,2.8) <.0001 Ref 1.2 (0.8,1.8) 0.2946 1.5 (1.0,2.1) 0.0318 2.5 (1.8,3.5) <0.0001Imaging
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Purpose: Identiﬁcation of biomarkers associated with OA disease pro-
gression is of critical importance to advance the development of disease
modifying therapies. The objective of this study is to investigate if
change in semi-quantitative measures of joint morphology over 24
months is associated with clinically relevant progression in knee OA
over a 48-month follow-up period.
Methods: The FNIH OA Biomarkers Consortium undertook a nested case-
control study of progressive knee OA within the Osteoarthritis Initiative
(OAI). The case group (n ¼ 194) is deﬁned by the combination of knee
radiographic outcome (medial tibiofemoral joint space loss (mTF JSL)
0.7 mm) and symptom outcome (persistent worsening inWOMAC pain
score, reaching a minimum clinically important threshold of 9 points
(change from baseline) on a 0-100 normalised scale), each achieved for
the ﬁrst time at the 24, 36 or 48 month follow-up compared to baseline.
Main inclusion criteria were a Kellgren Lawrence grade (KLG) 1, 2 or 3 at
baseline from central reading and availability of knee radiograph and
magnetic resonance images (MRIs) at baseline and 24 months. Controls
(n ¼ 406) were knees eligible for the study that did not meet both
endpoint criteria, and consisted of: 200 super controls with noworsening
of either factor (pain or mTF JSL), 103 subjects with JSL but no pain
increase and 103with a persistent increase in pain but not JSL. KneeMRIs(not contrast enhanced) at baseline, 12 and 24 months were scored using
the MRI Osteoarthritis Knee Score grading systems for bone marrow
lesions (BMLs), intercondylar synovitis and effusion. BML, synovitis and
effusion score changes were categorized as improved, no change, wors-
ened within grade, worsened by one grade, or worsened by more than
one grade. Analyses were performed for change in the whole knee and,
for BMLs only, also for change in the medial tibio-femoral compartment.
Logistic regressionwas used to assess the risk of case status adjusting for
baseline age, sex, BMI, KLG and baseline pain.
Results: 194 cases of mean age 62 years, mean BMI 30.7 and 57% female
were compared to 406 controls of mean age 61 years, mean BMI 30.7 and
60% female. BML change from BL to 24 months was associated with case
status - particularly the maximum change in BML score in the medial
tibiofemoral compartmentOR 1.5 (95%CI 1.3,1.8) and change innumberof
subregions affected in the medial tibiofemoral compartment OR 1.5 (95%
CI 1.1,1.8) (Table). Change in effusion, OR 2.2 (95% CI 1.6,2.8), and synovitis,
OR 2.2 (95% CI 1.4,3.6), were both strong predictors of case status. There
were differential effects of BML change on the 3 types of case status (pain
case vs. JSL case vs. JSL and pain case, each compared to super controls)
with strong association with JSL cases as opposed to pain cases.
Conclusion: Change in semi-quantitative MRI features (BMLs, synovitis
and effusion) are potent predictors of clinical outcome. Intriguingly, the
prediction of clinical outcome from BMLs, synovitis and effusion
appears to be associated with stronger effects on structure.428
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Purpose: Quantitative MRI (qMRI) measures in knee osteoarthritis (OA)
capable of predicting key clinical endpoints such as total knee
replacement (TKR) have promise as prognostic biomarkers. Recently, it
was reported that very large BML volume (measured semi-quantita-
tively) in the medial tibiofemoral joint predicted a TKR 1 year later. We
now use a recently validated rapid qMRI software tool to examine
whether BML volume and change in volume predicts TKR 1 and 2 years
later. The purpose of this study was to examine the longitudinal rela-
tionship between BML volume and those who received a TKR, com-
pared with control knees with the same radiographic grade that did not
receive a TKR.
Materials and methods: A nested case-control study was conducted in
the Osteoarthritis Initiative (OAI), a multicenter cohort of 4796 partic-
ipants with or at risk for knee OA. Subjects who received TKR by the 48-
month visit who also had MRI scans (3T sagittal intermediate-weighted
turbo spin-echo fat-suppressed, 0.357  0.357  3.0 mm, TR 3200 ms,
TE 30 ms, intermediate-weighted) available for the 12 and 24 month
visit prior to the TKR were designated cases. Cases were matched 1:1
with subjects who did not receive TKR but were the same radiographic
disease grade (K–L grade score), same gender and age of the case.
Quantitative BML volumes in the tibia, femur and patella were
